RPGLIFENSERPG Life Sciences Limited· PharmaceuticalsMediumNeutral
Announced Tue, 9 Jun · 12:31 IST

Swallow Associates LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Ownership Changes View source PDF

RPGLIFE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.6%1-day move
₹2072.00
prior close
₹2119.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.3-0.3-0.5+2.6+5.8+7.6+10.4+9.9+9.8+13.0+28.6
Up moveDown movePending
AI summary

Swallow Associates LLP, part of the promoter group of RPG Life Sciences, has submitted a disclosure to the exchange under Regulation 31(4) of SEBI's Takeover Regulations. This regulation requires promoters and promoter group entities to disclose details of any pledge or encumbrance created on their shares in the company. The filing indicates there has been some change relating to encumbrance of promoter-group shares, though the specific details (whether it is a new pledge, release, or invocation, and the percentage of shares involved) are not visible in this announcement. Investors should review the detailed disclosure to understand the nature and size of the encumbrance.

Likely market impact

Promoter pledge disclosures are closely watched by investors as high pledging can indicate financial stress, while releases may signal improved promoter liquidity. Without the specifics of this disclosure, no immediate price impact can be determined; investors should check the detailed filing before drawing conclusions.